HNRNPA1 Gene

📖 Wiki Page

gene695 wordssynced 2026-04-02

HNRNPA1 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">HNRNPA1 — Heterogeneous Nuclear Ribonucleoprotein A1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HNRNPA1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Heterogeneous Nuclear Ribonucleoprotein A1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>12q13.13</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/3178" target="_blank">3178</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166086" target="_blank">ENSG00000166086</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/164017" target="_blank">164017</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P09651" target="_blank">P09651</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Amyotrophic Lateral Sclerosis](/diseases/als), [Inclusion Body Myopathy](/diseases/inclusion-body-myopathy), [Frontotemporal Dementia](/diseases/ftd)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous, High in brain, spinal cord, muscle</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">Asp262Val<br>Gly295Ser<br>Gly298Arg<br>Asp314Val<br>Phe316Leu</td>
</tr>
</table>

...

HNRNPA1 Gene

HNRNPA1 — Heterogeneous Nuclear Ribonucleoprotein A1

Pathway Diagram

Mermaid diagram (expand to render)

Introduction

Hnrnpa1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

HNRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) is a gene encoding an RNA-binding protein that plays critical roles in RNA processing, splicing, and transport. Pathogenic mutations in HNRNPA1 cause familial amyotrophic lateral sclerosis (ALS), inclusion body myopathy (IBM), and frontotemporal dementia (FTD)[@kim2013].

Function

HNRNPA1 is a member of the hnRNP A/B family of RNA-binding proteins with multiple cellular functions:

RNA Processing

Pre-mRNA splicing: HNRNPA1 is a core component of the spliceosome
Alternative splicing: Regulates inclusion/exclusion of exons
RNA stability: Binds to AU-rich elements to regulate mRNA half-life

RNA Transport

Nuclear export: Facilitates export of processed mRNAs
Localization: Directs specific mRNAs to subcellular compartments

Stress Response

Stress granules: Aggregates into stress granules under cellular stress
Translation regulation: Represses translation during stress

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

HNRNPA1 mutations cause autosomal dominant ALS, typically with combined upper and lower motor neuron involvement. The disease mechanism involves:

RNA dysregulation: Altered splicing of essential neuronal transcripts

Stress granule pathology: Aberrant stress granule formation

Toxic gain-of-function: Formation of RNA foci that sequester essential proteins

Inclusion Body Myopathy (IBM)

Some HNRNPA1 mutations cause autosomal dominant inclusion body myopathy, characterized by:

Progressive muscle weakness
Rimmed vacuoles in muscle fibers
Often associated with FTD (ALS/IBM/FTD spectrum)

Frontotemporal Dementia (FTD)

HNRNPA1 mutations can cause FTD with or without motor neuron disease, sharing pathological features with ALS including [TDP-43](/proteins/tdp-43) pathology[@alternate2013].

Mechanisms of Neurodegeneration

| Mechanism | Description |
|-----------|-------------|
| RNA splicing defects | Mis-splicing of transcripts essential for neuronal survival |
| Stress granule accumulation | Persistent granules that disrupt translation |
| Nuclear import defects | Impaired nuclear-cytoplasmic transport |
| Protein aggregation | Formation of insoluble inclusions |

Therapeutic Targeting

Therapeutic strategies for HNRNPA1-related disorders include:

ASO therapy: Antisense oligonucleotides to reduce mutant HNRNPA1 expression
Small molecule modulators: Compounds that normalize splicing
Gene therapy: AAV-delivered HNRNPA1 or splicing modifiers

External Links

[NCBI Gene: HNNRPA1](https://www.ncbi.nlm.nih.gov/gene/3178)
[UniProt: HNRNPA1](https://www.uniprot.org/uniprot/P09651)
[Ensembl: HNRNPA1](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166086)

Animal Models

hnRNPA1 Knock-in Mice: Recapitulate ALS phenotype with motor neuron degeneration
Drosophila Models: Show locomotion deficits and reduced lifespan
Zebrafish Models: Demonstrate motor axon guidance defects

Therapeutic Approaches

Gene Therapy

Allele-Specific siRNA: Targeting mutant HNNRPA1 transcripts

CRISPR Editing: Correcting pathogenic mutations

AAV Delivery: Wild-type HNRNPA1 or splicing modifiers

Small Molecule Strategies

Splicing Modifiers: Antisense oligonucleotides to normalize splicing
Protein Stabilizers: Compounds that stabilize the native protein
Aggregation Inhibitors: Preventing toxic oligomer formation

Research Directions

Current areas of investigation include:

Understanding the mechanistic link between splicing dysfunction and motor neuron death
Developing biomarkers for HNRNPA1-related disease
Screening for small molecules that restore normal splicing patterns
Investigating the interplay between HNRNPA1 and other ALS/FTD proteins

Background

The study of Hnrnpa1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Kim HJ, Kim NC, Wang YD, et al, Mutations in the prion-like domains of hnRNPA1 and hnRNPA2B1 cause familial amyotrophic lateral sclerosis (2013)](https://pubmed.ncbi.nlm.nih.gov/24060820/)

[Unknown, Alternate splicing factor mutations in ALS/FTD (2013)](https://pubmed.ncbi.nlm.nih.gov/24093116/)

Pathway Diagram

The following diagram shows the key molecular relationships involving HNRNPA1 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

HNRNPA1 Gene

HNRNPA1 Gene

HNRNPA1 Gene

HNRNPA1 — Heterogeneous Nuclear Ribonucleoprotein A1

Pathway Diagram

Introduction

Overview

Function

RNA Processing

RNA Transport

Stress Response

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

Inclusion Body Myopathy (IBM)

Frontotemporal Dementia (FTD)

Mechanisms of Neurodegeneration

Therapeutic Targeting

See Also

External Links

Animal Models

Therapeutic Approaches

Gene Therapy

Small Molecule Strategies

Research Directions

Background

References

Pathway Diagram